DigestRedComo funciona
Red
/
Empresas
Xy
No verificado

XyloCor Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaCardiologíaFarmacéuticaMedicina - VariosSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa
05/03/2026
Mercado laboral
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Cardiología
XyloCor Appoints John Tucker as President and Chief Executive Officer
Fuente
XyloCor Therapeutics, Inc.
Editor
Business Wire
1.00
0
10/07/2025
Medicina - Varios
Higiene alimentaria
Biotecnología
Cardiología
Sanidad
Farmacéutica
Salud
Oncología
Industria
First Patient Dosed in XyloCor Therapeutics’ Phase 2b EXACT-2 Trial Evaluating XC001 for the Treatment of Coronary Artery Disease
Fuente
XyloCor Therapeutics, Inc.
Editor
Business Wire
1.00
0
07/01/2025
Industria
Salud
Medicina - Varios
Biotecnología
Farmacéutica
Cardiología
XyloCor Therapeutics Raises $67.5 Million in Series B Financing to Advance Clinical Development of Novel Gene Therapy in Cardiovascular Disease
Fuente
XyloCor Therapeutics, Inc.
Editor
Business Wire
1.00
0
10/07/2024
Mercado laboral
Material médico sanitario
Salud
Biotecnología
Medicina - Varios
Cardiología
XyloCor Therapeutics and SmartCella Enter into License Agreement for Use of the Extroducer Infusion Catheter System to Administer Novel Gene Therapy XC001 to the Heart
Fuente
XyloCor Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0